List view / Grid view
7 July 2015 | By Victoria White
The first patients have been enrolled in a Phase 2b clinical trial of Pfizer’s S. aureus vaccine in adults undergoing elective spinal fusion surgery...
7 July 2015 | By Victoria White
Allergan is to acquire exclusive worldwide rights to Merck's CGRP receptor antagonists, which are being developed for the treatment of migraine...
7 July 2015 | By Victoria White
Testing thousands of approved drugs, EPFL scientists have found that an over-the-counter antacid, lansoprazole, may be an effective anti-tuberculosis drug...
7 July 2015 | By Victoria White
A new investigational vaccine designed to protect against West Nile Virus infection is being tested in a Phase 1 clinical trial...
7 July 2015 | By Victoria White
BARDA, a division of the US Department of Health & Human Services, has ordered a bulk supply of Bavarian Nordic’s Imvamune non-replicating smallpox vaccine...
6 July 2015 | By Victoria White
Results from the LUX-Lung 8 Trial demonstrate that afatinib resulted in superior progression-free survival and overall survival compared to erlotinib...
6 July 2015 | By Victoria White
Over three quarters of UK GPs think their patients with dementia rely on family as they do not get enough help from health and social care services...
6 July 2015 | By Victoria White
Allergan is to acquire Oculeve. The acquisition will add novel, complementary dry eye development programmes to Allergan's portfolio...
6 July 2015 | By Victoria White
Despite being preventable thanks to vaccines, over 60,000 people die from rabies each year making it one of the world’s most deadly infectious diseases...
6 July 2015 | By Victoria White
Results from a study on the efficacy of cetuximab plus FOLFOX chemo as second-line treatment for patients with mCRC were presented at the ESMO 2015 congress...
3 July 2015 | By Victoria White
ViiV Healthcare and Desano Pharmaceuticals have announced a strategic manufacturing agreement to enable production of dolutegravir in China...
3 July 2015 | By Victoria White
A study has found that it may be possible to predict early which rheumatoid arthritis patients will fail to respond to the biologic drugs given to them...
3 July 2015 | By Victoria White
The EC has approved Janssen’s Stelara for the treatment of moderate-to-severe plaque psoriasis in adolescent patients from the age of 12 years and older...
3 July 2015 | By Victoria White
The FDA has approved Vertex’s Orkambi, the first medicine to treat the underlying cause of cystic fibrosis in people with two copies of the F508del mutation...
3 July 2015 | By Victoria White
The FDA has accepted for review Pfizer’s new drug application (NDA) for Xeljanz (tofacitinib citrate) 11 mg once daily modified release tablets...
